Efficacy and safety of short duration radiotherapy combined with chemotherapy for advanced rectal cancer

Table 1 Differences in the expression of Runx3 and Ki-67 from the biopsy between two groups before and after the treatment, n (%)

Groups	n	Time point	Runx3		Ki-67
			Positive	Negative	Positive	Negative
Observation group	50	Before the treatment	26 (2.0)	24 (48.0)	46 (92.0)	4 (8.0)
		After the treatment	38 (76.0)a	12 (24.0)	37 (74.0)a	12 (26.0)
Control group	50	Before the treatment	27 (54.0)	23 (46.0)	45 (90.0)	5 (10.0)
		After the treatment	34 (68.0)a	16 (32.0)	36 (72.0)a	14 (28.0)

Compared with those before the treatment.

^aP < 0.05.